Gene · 435
Papers1,794
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,794
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Evolution of Nitric Oxide Function: From Reactivity in the Prebiotic Earth to Examples of Biological Roles and Therapeutic Applications. | Antioxidants (Basel) | 2022 | 35883712 | PubTator, text mining | PubMed |
| Genetic Control of Kinetochore-Driven Microtubule Growth in Drosophila Mitosis. | Cells | 2022 | 35883570 | PubTator, text mining | PubMed |
| Genetic Diagnosis in a Cohort of Adult Patients with Inherited Metabolic Diseases: A Single-Center Experience. | Biomolecules | 2022 | 35883476 | PubTator, text mining | PubMed |
| Activation of VIPR1 suppresses hepatocellular carcinoma progression by regulating arginine and pyrimidine metabolism. | Int J Biol Sci | 2022 | 35864952 | PubTator, text mining | PubMed |
| Centriole growth is limited by the Cdk/Cyclin-dependent phosphorylation of Ana2/STIL. | J Cell Biol | 2022 | 35861803 | PubTator, text mining | PubMed |
| I See What You Are Saying: Hearing Infants' Visual Attention and Social Engagement in Response to Spoken and Sign Language. | Front Psychol | 2022 | 35846705 | PubTator, text mining | PubMed |
| A Novel Composite Indicator of Predicting Mortality Risk for Heart Failure Patients With Diabetes Admitted to Intensive Care Unit Based on Machine Learning. | Front Endocrinol (Lausanne) | 2022 | 35846312 | PubTator, text mining | PubMed |
| GCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatment. | Cell Metab | 2022 | 35839757 | PubTator, text mining | PubMed |
| Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery. | Nat Commun | 2022 | 35831314 | PubTator, text mining | PubMed |
| Molecular Aspects of Distal Kidney Tubular Acidosis in Children, Its Long-Term Outcome, and Relationship with Hyperammonemia. | Turk Arch Pediatr | 2022 | 35822476 | PubTator, text mining | PubMed |
| Hepatic Encephalopathy Is Not Always due to Liver Cirrhosis. | Case Rep Gastroenterol | 2022 | 35814799 | PubTator, text mining | PubMed |
| Arginase: Mechanisms and Clinical Application in Hematologic Malignancy. | Front Oncol | 2022 | 35814439 | PubTator, text mining | PubMed |
Measuring Non-Destructively the Total Indium Content and Its Lateral Distribution in Very Thin Single Layers or Quantum Dots Deposited onto Gallium Arsenide Substrates Using Energy-Dispersive X-ray Spectroscopy in a Scanning Electron Microscope. | Nanomaterials (Basel) | 2022 | 35808054 | PubTator, text mining | PubMed |
| Oral and gut dysbiosis leads to functional alterations in Parkinson's disease. | NPJ Parkinsons Dis | 2022 | 35798742 | PubTator, text mining | PubMed |
| Characterisation of Expression the Arginine Pathway Enzymes in Childhood Brain Tumours to Determine Susceptibility to Therapeutic Arginine Depletion. | Biomed Res Int | 2022 | 35782058 | PubTator, text mining | PubMed |
| Metabolic Reprogramming in Hematologic Malignancies: Advances and Clinical Perspectives. | Cancer Res | 2022 | 35771627 | PubTator, text mining | PubMed |
| Convergent and Divergent Age Patterning of Gut Microbiota Diversity in Humans and Nonhuman Primates. | mSystems | 2022 | 35758593 | PubTator, text mining | PubMed |
| Strong Selectional Forces Fine-Tune CpG Content in Genes Involved in Neurological Disorders as Revealed by Codon Usage Patterns. | Front Neurosci | 2022 | 35757545 | PubTator, text mining | PubMed |
| Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches. | Pharmaceutics | 2022 | 35745875 | PubTator, text mining | PubMed |
| Management of Combined Therapy (Ceritinib, A. cinnamomea, G. lucidum, and Photobiomodulation) in Advanced Non-Small-Cell Lung Cancer: A Case Report. | Life (Basel) | 2022 | 35743893 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/435/papers?page=16